Restart Life Sciences Corp. (CSE:HEAL)

Canada flag Canada · Delayed Price · Currency is CAD
0.1000
0.00 (0.00%)
At close: Feb 25, 2026
Market Cap5.93M +166.3%
Revenue (ttm)n/a
Net Income-1.23M
EPS-0.05
Shares Out59.25M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume13,000
Average Volume30,907
Open0.1000
Previous Close0.1000
Day's Range0.1000 - 0.1000
52-Week Range0.0450 - 0.1400
Beta-1.02
RSI45.43
Earnings DateApr 8, 2026

About Restart Life Sciences

Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company worldwide. It engages in developing natural remedies specifically tailored for individuals on the autism spectrum; health-related foods that promote both mind and body wellness for healthy living, as well as psilocybin clinical trial for fragile X syndrome. The company was formerly known as Nova Mentis Life Science Corp. and changed its name to Restart Life Sciences Corp. in November 2024. Restart Life Sciences Corp. was incorporated in 2004 and is based ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol HEAL
Full Company Profile

Financial Performance

Financial Statements